Current Report Filing (8-k)
28 January 2023 - 08:22AM
Edgar (US Regulatory)
0001040470false00010404702023-01-242023-01-24iso4217:USDxbrli:sharesiso4217:USDxbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported)
January 24, 2023

AEHR TEST
SYSTEMS
|
(Exact name of registrant as specified in its charter)
|
California
|
|
000-22893
|
|
94-2424084
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
|
400 KATO TERRACE
FREMONT, CA 94539
|
(Address of principal executive offices, including zip code)
|
|
510-623-9400
|
(Registrant’s telephone number, including area code)
|
|
N/A
|
(Former name or former address, if changed since last report)
|
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
☐
|
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If
an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange
on which registered
|
Common Stock
|
|
AEHR
|
|
The NASDAQ Capital Market
|
Item 5.02 Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.
(b) On January 24, 2023, Mario Rosati retired as a director of Aehr
Test Systems (the “Company”). Mr. Rosati’s action was voluntary and
did not result from any disagreement with the Company or the
Company’s Board of Directors (the “Board”).
(d) On January 25, 2023 the Board appointed existing director Rhea
Posedel to the Corporate Governance and Nominating Committee,
replacing Mr. Rosati in this position.
A copy of the press release announcing Mr. Rosati’s retirement and
change to the Board committee is attached hereto as Exhibit 99.1
and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
|
Aehr Test Systems
(Registrant)
|
|
|
|
|
|
Date: January 27, 2023 |
By: |
/s/ Kenneth B.
Spink |
|
|
|
Kenneth B. Spink |
|
|
|
Vice President of Finance and |
|
|
|
Chief Financial Officer |
|
Aehr Test Systems (NASDAQ:AEHR)
Historical Stock Chart
From Feb 2023 to Mar 2023
Aehr Test Systems (NASDAQ:AEHR)
Historical Stock Chart
From Mar 2022 to Mar 2023